FRONTEO,Inc. (2158) Income statement

Market cap
¥23.3B
P/E ratio
155x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
2012/032013/032014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/032026/03
Revenue5,1334,6804,1726,27410,55311,20812,21811,26210,47110,37010,9337,2157,3756,0997,643
Revenue growth (%)-
Cost of revenue---3,1435,8506,8746,9916,3286,4285,5885,3593,9543,6502,6473,737
Gross profit---3,1314,7034,3345,2274,9344,0434,7825,5743,2613,7253,4533,906
Gross margin (%)---
Operating margin (%)---
Operating expenses ---2,8654,6335,5415,0494,6894,8874,2753,8524,6233,9102,9253,167
Operating income ---26669-1,207178244-8445071,722-1,362-185528739
Income before tax 2,286872-63043423-1,255-17203-9923301,687-1,293-168544675
Pretax margin (%)44.518.6-15.16.90.2-11.2-0.11.8-9.53.215.4-17.9-2.38.98.8
Provision for income taxes---172182-429-43168-3411308-86-309121
Effective tax rate (%)---
Net income 1,272484-603262-191-942-81862-9133661,309-1,701-2,843555859
Earnings per share49.1315.84-17.747.45-5.53-26.07-21.791.37-24.379.3333.35-43.27-72.2514.113.86
Diluted EPS40.2315.39-7.27---1.31-9.3233.11--14.1-
Dividend payout ratio (%)--------------
Dividend per share----------7----
AI Chat